Kura Oncology (KURA) Earnings Date, Estimates & Call Transcripts $6.28 -0.08 (-1.26%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$6.28 +0.00 (+0.08%) As of 07/11/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Kura Oncology Earnings Summary Kura Oncology released Q1 2025 earnings on May 1, 2025, reporting an EPS of -$0.66, which missed the consensus estimate of -$0.51 by $0.15. Quarterly revenue was reported to be $14.11 million, below the consensus estimate of $39.08 million. With a trailing EPS of -$2.10, Kura Oncology's earnings are expected to grow next year, from ($2.44) to ($1.72) per share. Upcoming Q2 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (May. 1) -$0.51 Actual EPS (May. 1) -$0.66 Missed By -$0.15 Actual Revenue (May. 1) $14.11MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)KURA Upcoming EarningsKura Oncology's next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Kura Oncology Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kura Oncology and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataKURA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KURA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Kura Oncology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$0.87$0.15-$0.51Q2 20254-$0.95$0.14-$0.53Q3 20254-$0.76$1.36$0.06Q4 20254-$1.05$0.18-$0.52 Kura Oncology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/1/2025Q1 2025-$0.51-$0.66 -$0.15-$0.66$39.08M$14.11M2/26/2025Q4 2024-$0.65-$0.22+$0.43-$0.22$57.96M$53.88M11/7/2024Q3 2024-$0.64-$0.63+$0.01-$0.63--8/8/2024Q2 2024-$0.63-$0.59+$0.04-$0.59--5/14/2024Q1 2024--$1.75--$0.05--5/2/2024Q1 2024-$0.56-$0.59 -$0.03-$0.59--2/27/2024Q4 2023-$0.56-$0.55+$0.01-$0.55--2/14/2024Q4 2023--$8.40--$0.24--11/13/2023Q3 2023--$64.05--$1.83--11/2/2023Q3 2023-$0.56-$0.50+$0.06-$0.50-- Get the Latest News and Ratings for KURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter. 9/18/2023Q4 2023-$6.30-$68.25 -$61.95-$1.95--8/3/2023Q2 2023-$0.57-$0.53+$0.04-$0.53-- Kura Oncology Earnings - Frequently Asked Questions When is Kura Oncology's earnings date? Kura Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on KURA's earnings history. Did Kura Oncology beat their earnings estimates last quarter? In the previous quarter, Kura Oncology (NASDAQ:KURA) missed the analysts' consensus estimate of ($0.51) by $0.15 with a reported earnings per share (EPS) of ($0.66). Learn more on analysts' earnings estimate vs. KURA's actual earnings. How can I listen to Kura Oncology's earnings conference call? The conference call for Kura Oncology's latest earnings report can be listened to online. Listen to Conference Call How can I read Kura Oncology's conference call transcript? The conference call transcript for Kura Oncology's latest earnings report can be read online. Read Transcript How much revenue does Kura Oncology generate each year? Kura Oncology (NASDAQ:KURA) has a recorded annual revenue of $53.88 million. How much profit does Kura Oncology generate each year? Kura Oncology (NASDAQ:KURA) has a recorded net income of -$173.98 million. KURA has generated -$2.10 earnings per share over the last four quarters. What is Kura Oncology's EPS forecast for next year? Kura Oncology's earnings are expected to grow from ($2.44) per share to ($1.72) per share in the next year. More Earnings Resources from MarketBeat Related Companies BEAM Earnings IDYA Earnings IRON Earnings BLTE Earnings CNTA Earnings HRMY Earnings ADPT Earnings SRPT Earnings TARS Earnings IMCR Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:KURA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
